Site-Specific Steric Control of SARS-CoV-2 Spike Glycosylation.
Allen JD. et al, (2021), Biochemistry
Bispecific repurposed medicines targeting the viral and immunological arms of COVID-19.
Redhead MA. et al, (2021), Scientific reports, 11
Reduced neutralization of SARS-CoV-2 B.1.617 by vaccine and convalescent serum.
Liu C. et al, (2021), Cell
Quantitative SARS-CoV-2 anti-spike responses to Pfizer-BioNTech and Oxford-AstraZeneca vaccines by previous infection status.
Eyre DW. et al, (2021), Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases
Focus of our research
To understand the biology of viruses and how they infect their host cells, it is important to be able to study the viruses in their infectious native state and also in their cellular context.
Groups in OPIC focus in studying structures of purified virus particles and virus host-cell interactions. OPIC houses state-of-the-art biosafety containment laboratories at ACDP category 3 and DEFRA 4 levels of containment. This facilitates the study of a number of viruses that are important to human and animal health.
Examples of our research
STRUCTURAL CELL BIOLOGY OF VIRUS INFECTION
Kay Grünewald - Our aim is a comprehensive picture of the functional interaction between viral protein complexes and cellular structures in the course of the infection. Viruses being studied include Herpes simplex virus type 1 and HIV. Read full biography
STRUCTURES AND HOST CELL INTERACTIONS OF EMERGING VIRUSES
Juha Huiskonen - We study the ultrastructure and cell entry mechanisms of viruses causing heamorrhagic fevers. Current focus is members of Arenaviridae (Lassa virus) and Bunyaviridae (Rift Valley fever virus). Read full biography
A PIPELINE FOR STRUCTURAL VACCINOLOGY
Dave Stuart - We use atomic resolution structures of viral particles to guide the design of stabilized vaccines. This ‘structural vaccinology’ approach is used for the development of a safe, synthetic stabilised virus-like particle (VLP) based vaccine for foot and-mouth disease virus and poliovirus. Read full biography